索克斯莱特叶子提取物的抗活性
Tesfaye Desalegn1, Ephrem Engidawork1
1Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Journal of experimental pharmacology
|June 5, 2023
概括
在动物模型中,Ajuga integrifolia叶表现出显著的抗活性,验证了传统的埃塞俄比亚医学. 这种植物是开发新抗药物的有希望的来源,特别是用于耐药性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 民族植物学 民族植物学
- 神经科学是一个神经科学.
背景情况:
- 在埃塞俄比亚,Ajuga integrifolia (Lamiaceae) 叶子传统上用于治疗.
- 现有的科学证据支持这种传统用途是有限的.
- 这项研究旨在科学评估A. integrifolia的抗性质.
研究的目的:
- 为了研究Ajuga integrifolia叶片提取物的抗活性.
- 在扣押模型中评估不同溶剂提取物的有效性.
- 为了确定活性提取物的植物化学特征 (类,黄类,类).
主要方法:
- 在小鼠中使用急性 (pentylenetetrazol [PTZ],最大电击 [MES]) 和慢性 (PTZ kindling) 发作模型测试了抗发作作用.
- 多种剂量 (100,200,400毫克/公斤) 的植物提取物被使用.
- 记录的关键参数包括发作的发作和持续时间,与标准抗药物 (甲,芬) 的比较.
主要成果:
- 乙酸乙烯提取物在所有测试模型中表现出卓越的抗活性.
- 这种提取物在PTZ测试中显著延迟了发作,并在MES测试中减少了发作持续时间 (p<0.01).
- 提取物还在200和400毫克/公斤 (p<0.001) 的剂量下显著保护PTZ诱导的点火.
结论:
- 在急性和慢性发作模型中,Ajuga integrifolia表现出显著的抗性质.
- 这种植物含有大量的类化合物,黄类化合物和类.
- A. integrifolia代表了开发新型抗药物的潜在自然来源,特别是对于耐药性.
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
351
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
351
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
473
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
473
01:14Antiepileptic Drugs: Glutamate Antagonists
435
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
435
01:26Anxiolytic Drugs: Overview
373
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
373
01:20Antiepileptic Drugs: Potassium Channel Activators
219
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
219
01:33Pleiotropy
40.7K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.7K